{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T03:59:10Z","timestamp":1782705550981,"version":"3.54.5"},"reference-count":57,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The low abundance of Hodgkin\/Reed-Sternberg (HRS) cells in lymph node biopsies in classical Hodgkin lymphoma (cHL) complicates the analysis of somatic genetic alterations in HRS cells. As circulating cell-free DNA (cfDNA) contains circulating tumor DNA (ctDNA) from HRS cells, we prospectively collected cfDNA from 177 patients with newly diagnosed, mostly early-stage cHL in a monocentric study at Leuven, Belgium (n = 59) and the multicentric BREACH study by Lymphoma Study Association (n = 118). To catalog the patterns and frequencies of genomic copy number aberrations (CNAs), cfDNA was sequenced at low coverage (0.26\u00d7), and data were analyzed with ichorCNA to yield read depth-based copy number profiles and estimated clonal fractions in cfDNA. At diagnosis, the cfDNA concentration, estimated clonal fraction, and ctDNA concentration were significantly higher in cHL cases than controls. More than 90% of patients exhibited CNAs in cfDNA. The most frequent gains encompassed 2p16 (69%), 5p14 (50%), 12q13 (50%), 9p24 (50%), 5q (44%), 17q (43%), 2q (41%). Losses mostly affected 13q (57%), 6q25-q27 (55%), 4q35 (50%), 11q23 (44%), 8p21 (43%). In addition, we identified loss of 3p13-p26 and of 12q21-q24 and gain of 15q21-q26 as novel recurrent CNAs in cHL. At diagnosis, ctDNA concentration was associated with advanced disease, male sex, extensive nodal disease, elevated erythrocyte sedimentation rate, metabolic tumor volume, and HRS cell burden. CNAs and ctDNA rapidly diminished upon treatment initiation, and persistence of CNAs was associated with increased probability of relapse. This study endorses the development of ctDNA as gateway to the HRS genome and substrate for early disease response evaluation.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020003039","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T18:44:40Z","timestamp":1618253080000},"page":"1991-2002","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":40,"title":["The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2320-8379","authenticated-orcid":false,"given":"Lieselot","family":"Buedts","sequence":"first","affiliation":[{"name":"Department of Human Genetics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Wlodarska","sequence":"additional","affiliation":[{"name":"Department of Human Genetics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Finalet-Ferreiro","sequence":"additional","affiliation":[{"name":"Genomics Core, KU Leuven, Leuven, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-9675","authenticated-orcid":false,"given":"Olivier","family":"Gheysens","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1691-0503","authenticated-orcid":false,"given":"Luc","family":"Dehaspe","sequence":"additional","affiliation":[{"name":"Genomics Core, KU Leuven, Leuven, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0397-1086","authenticated-orcid":false,"given":"Thomas","family":"Tousseyn","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospitals Leuven, Leuven, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1866-971X","authenticated-orcid":false,"given":"Luc-Matthieu","family":"Fornecker","sequence":"additional","affiliation":[{"name":"CHU Strasbourg, Strasbourg, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Lazarovici","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gustave Roussy and Universit\u00e9 Paris Saclay, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1156-8983","authenticated-orcid":false,"given":"Ren\u00e9-Olivier","family":"Casasnovas","sequence":"additional","affiliation":[{"name":"CHU Le Bocage, Dijon, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Claire","family":"Gac","sequence":"additional","affiliation":[{"name":"Institute of Hematology of Lower Normandy, CHU de Caen Normandy, Normandy, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Bonnet","sequence":"additional","affiliation":[{"name":"University Hospitals Liege, Liege, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-7823","authenticated-orcid":false,"given":"Kamal","family":"Bouabdallah","sequence":"additional","affiliation":[{"name":"CHU Hematology Haut-L\u00e9v\u00eaque, Pessac, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5408-894X","authenticated-orcid":false,"given":"Christiane","family":"Copie-Bergman","sequence":"additional","affiliation":[{"name":"H\u00f4pital Henri Mondor, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1865-2587","authenticated-orcid":false,"given":"Bettina","family":"Fabiani","sequence":"additional","affiliation":[{"name":"H\u00f4pital Saint-Antoine, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8917-022X","authenticated-orcid":false,"given":"Daan","family":"Dierickx","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Hospitals Leuven, Leuven, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5446-1801","authenticated-orcid":false,"given":"Lukas","family":"Marcelis","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospitals Leuven, Leuven, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3071-1191","authenticated-orcid":false,"given":"Joris","family":"Vermeesch","sequence":"additional","affiliation":[{"name":"Department of Human Genetics and"},{"name":"Genomics Core, KU Leuven, Leuven, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7101-810X","authenticated-orcid":false,"given":"Marc","family":"Andr\u00e9","sequence":"additional","affiliation":[{"name":"CHU UCL Namur, Namur, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4719-1935","authenticated-orcid":false,"given":"Peter","family":"Vandenberghe","sequence":"additional","affiliation":[{"name":"Department of Human Genetics and"},{"name":"Department of Hematology, University Hospitals Leuven, Leuven, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"issue":"15","key":"2021041215330113000_B1","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood-2017-09-772632","article-title":"Biology of classical Hodgkin lymphoma: implications for prognosis and novel therapies","volume":"131","author":"Mottok","year":"2018","journal-title":"Blood"},{"issue":"suppl 4","key":"2021041215330113000_B2","doi-asserted-by":"crossref","first-page":"iv19","DOI":"10.1093\/annonc\/mdy080","article-title":"Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Eichenauer","year":"2018","journal-title":"Ann Oncol"},{"issue":"10","key":"2021041215330113000_B3","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI61245","article-title":"Hodgkin lymphoma","volume":"122","author":"K\u00fcppers","year":"2012","journal-title":"J Clin Invest"},{"issue":"7","key":"2021041215330113000_B4","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","article-title":"Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells","volume":"125","author":"Reichel","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2021041215330113000_B5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood-2009-12-257345","article-title":"Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome","volume":"116","author":"Steidl","year":"2010","journal-title":"Blood"},{"issue":"9","key":"2021041215330113000_B6","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3324\/haematol.12875","article-title":"Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin\u2019s lymphoma by array-based comparative genomic hybridization","volume":"93","author":"Hartmann","year":"2008","journal-title":"Haematologica"},{"issue":"10","key":"2021041215330113000_B7","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1158\/1078-0432.CCR-10-1071","article-title":"Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma","volume":"17","author":"Slovak","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2021041215330113000_B8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2001.02566.x","article-title":"MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studies","volume":"112","author":"K\u00fcpper","year":"2001","journal-title":"Br J Haematol"},{"issue":"4","key":"2021041215330113000_B9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N Engl J Med"},{"issue":"17","key":"2021041215330113000_B10","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2021041215330113000_B11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/ejh.13033","article-title":"Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma","volume":"100","author":"Tanaka","year":"2018","journal-title":"Eur J Haematol"},{"issue":"11","key":"2021041215330113000_B12","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41374-018-0096-6","article-title":"Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues","volume":"98","author":"Juskevicius","year":"2018","journal-title":"Lab Invest"},{"issue":"5","key":"2021041215330113000_B13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/gcc.22345","article-title":"Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies","volume":"55","author":"Van Roosbroeck","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"23","key":"2021041215330113000_B14","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J Clin Oncol"},{"issue":"23","key":"2021041215330113000_B15","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","article-title":"Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion","volume":"3","author":"Wienand","year":"2019","journal-title":"Blood Adv"},{"issue":"22","key":"2021041215330113000_B16","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"issue":"13","key":"2021041215330113000_B17","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma","volume":"123","author":"Twa","year":"2014","journal-title":"Blood"},{"key":"2021041215330113000_B18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/1471-2407-12-457","article-title":"Deletion of the TNFAIP3\/A20 gene detected by FICTION analysis in classical Hodgkin lymphoma","volume":"12","author":"Nomoto","year":"2012","journal-title":"BMC Cancer"},{"issue":"1","key":"2021041215330113000_B19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/genes10010037","article-title":"Nonclonal chromosome aberrations and genome chaos in somatic and germ cells from patients and survivors of Hodgkin lymphoma","volume":"10","author":"Frias","year":"2019","journal-title":"Genes (Basel)"},{"issue":"10","key":"2021041215330113000_B20","first-page":"2606","article-title":"Allelic losses on chromosome 6q25 in Hodgkin and Reed Sternberg cells","volume":"63","author":"Re","year":"2003","journal-title":"Cancer Res"},{"issue":"4","key":"2021041215330113000_B21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood.V86.4.1464.bloodjournal8641464","article-title":"Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin\u2019s disease","volume":"86","author":"Weber-Matthiesen","year":"1995","journal-title":"Blood"},{"issue":"4","key":"2021041215330113000_B22","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V99.4.1381","article-title":"Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2","volume":"99","author":"Joos","year":"2002","journal-title":"Blood"},{"issue":"4","key":"2021041215330113000_B23","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood.V99.4.1474","article-title":"Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma","volume":"99","author":"Mart\u00edn-Subero","year":"2002","journal-title":"Blood"},{"issue":"2","key":"2021041215330113000_B24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/gcc.10266","article-title":"Classical Hodgkin lymphoma is associated with frequent gains of 17q","volume":"38","author":"Chui","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"2021041215330113000_B25","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2141.2008.07262.x","article-title":"Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines","volume":"142","author":"Giefing","year":"2008","journal-title":"Br J Haematol"},{"issue":"6","key":"2021041215330113000_B26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"162","key":"2021041215330113000_B27","doi-asserted-by":"crossref","first-page":"162ra154","DOI":"10.1126\/scitranslmed.3004742","article-title":"Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing","volume":"4","author":"Leary","year":"2012","journal-title":"Sci Transl Med"},{"issue":"4","key":"2021041215330113000_B28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nm.3511","article-title":"Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA","volume":"20","author":"Thierry","year":"2014","journal-title":"Nat Med"},{"issue":"45","key":"2021041215330113000_B29","doi-asserted-by":"crossref","first-page":"16368","DOI":"10.1073\/pnas.0507904102","article-title":"Detection and quantification of mutations in the plasma of patients with colorectal tumors","volume":"102","author":"Diehl","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"25","key":"2021041215330113000_B30","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood-2016-03-635219","article-title":"Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma","volume":"127","author":"Roschewski","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2021041215330113000_B31","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S2352-3026(14)00039-8","article-title":"Non-invasive detection of genomic imbalances in Hodgkin\/Reed-Sternberg cells in early and advanced stage Hodgkin\u2019s lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study","volume":"2","author":"Vandenberghe","year":"2015","journal-title":"Lancet Haematol"},{"issue":"22","key":"2021041215330113000_B32","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood-2017-11-812073","article-title":"Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma","volume":"131","author":"Spina","year":"2018","journal-title":"Blood"},{"issue":"2","key":"2021041215330113000_B33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/10428194.2018.1492123","article-title":"Somatic mutations of cell-free circulating DNA detected by targeted next-generation sequencing and digital droplet PCR in classical Hodgkin lymphoma","volume":"60","author":"Bessi","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2021041215330113000_B34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41375-019-0541-6","article-title":"Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma","volume":"34","author":"Desch","year":"2020","journal-title":"Leukemia"},{"issue":"21","key":"2021041215330113000_B35","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin\u2019s disease. International Prognostic Factors Project on Advanced Hodgkin\u2019s Disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"2021041215330113000_B36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/annonc\/mdy476","article-title":"Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors","volume":"30","author":"Lenaerts","year":"2019","journal-title":"Ann Oncol"},{"issue":"1","key":"2021041215330113000_B37","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s41467-017-00965-y","article-title":"Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors","volume":"8","author":"Adalsteinsson","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"2021041215330113000_B38","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"issue":"6","key":"2021041215330113000_B39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41592-019-0422-y","article-title":"CancerMine: a literature-mined resource for drivers, oncogenes and tumor suppressors in cancer","volume":"16","author":"Lever","year":"2019","journal-title":"Nat Methods"},{"issue":"6","key":"2021041215330113000_B40","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00259-014-2705-y","article-title":"Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients","volume":"41","author":"Meignan","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"2021041215330113000_B41","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/annonc\/mdp006","article-title":"Cell-free circulating DNA in Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas","volume":"20","author":"Hohaus","year":"2009","journal-title":"Ann Oncol"},{"issue":"67","key":"2021041215330113000_B42","doi-asserted-by":"crossref","first-page":"111386","DOI":"10.18632\/oncotarget.22799","article-title":"Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets","volume":"8","author":"Mata","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"2021041215330113000_B43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1634\/theoncologist.2018-0058","article-title":"Comprehensive genomic profiling of Hodgkin lymphoma reveals recurrently mutated genes and increased mutation burden","volume":"24","author":"Liang","year":"2019","journal-title":"Oncologist"},{"issue":"9","key":"2021041215330113000_B44","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3324\/haematol.2016.145102","article-title":"Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma","volume":"101","author":"Camus","year":"2016","journal-title":"Haematologica"},{"issue":"18","key":"2021041215330113000_B45","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1158\/1078-0432.CCR-18-0143","article-title":"False-positive plasma genotyping due to clonal hematopoiesis","volume":"24","author":"Hu","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2021041215330113000_B46","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/ng.2271","article-title":"Detectable clonal mosaicism from birth to old age and its relationship to cancer","volume":"44","author":"Laurie","year":"2012","journal-title":"Nat Genet"},{"issue":"6","key":"2021041215330113000_B47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ng.2270","article-title":"Detectable clonal mosaicism and its relationship to aging and cancer","volume":"44","author":"Jacobs","year":"2012","journal-title":"Nat Genet"},{"issue":"19","key":"2021041215330113000_B48","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1038\/sj.onc.1205418","article-title":"Gene expression profiling defines molecular subtypes of classical Hodgkin\u2019s disease","volume":"21","author":"Devilard","year":"2002","journal-title":"Oncogene"},{"issue":"1","key":"2021041215330113000_B49","doi-asserted-by":"crossref","first-page":"e2014053","DOI":"10.4084\/mjhid.2014.053","article-title":"Prognostic factors in Hodgkin lymphoma","volume":"6","author":"Cuccaro","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"6","key":"2021041215330113000_B50","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/sj.onc.1207313","article-title":"Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin\u2019s lymphoma","volume":"23","author":"Murray","year":"2004","journal-title":"Oncogene"},{"issue":"11","key":"2021041215330113000_B51","first-page":"910","article-title":"Classical Hodgkin lymphoma with reduced \u03b22M\/MHC expression is associated with inferior outcome independent of 9p24.1 status","volume":"4","author":"Roemer","year":"2017","journal-title":"Nat Genet"},{"issue":"17","key":"2021041215330113000_B52","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood-2012-06-439570","article-title":"Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma","volume":"120","author":"Steidl","year":"2012","journal-title":"Blood"},{"issue":"10","key":"2021041215330113000_B53","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1200\/JCO.2017.77.3994","article-title":"Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma","volume":"36","author":"Roemer","year":"2018","journal-title":"J Clin Oncol"},{"key":"2021041215330113000_B54","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.2147\/OTT.S168313","article-title":"Drug response to PD-1\/PD-L1 blockade: based on biomarkers","volume":"11","author":"Chen","year":"2018","journal-title":"OncoTargets Ther"},{"issue":"4","key":"2021041215330113000_B55","doi-asserted-by":"crossref","first-page":"FSO295","DOI":"10.4155\/fsoa-2017-0140","article-title":"Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature","volume":"4","author":"Khier","year":"2018","journal-title":"Futur Sci OA"},{"issue":"3","key":"2021041215330113000_B56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/path.2711","article-title":"The classical Hodgkin\u2019s lymphoma microenvironment and its role in promoting tumour growth and immune escape","volume":"221","author":"Aldinucci","year":"2010","journal-title":"J Pathol"},{"issue":"28","key":"2021041215330113000_B57","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1200\/JCO.2018.78.5246","article-title":"Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma","volume":"36","author":"Kurtz","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/7\/1991\/1804755\/advancesadv2020003039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/7\/1991\/1804755\/advancesadv2020003039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T18:45:24Z","timestamp":1618253124000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/7\/1991\/475688\/The-landscape-of-copy-number-variations-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,4,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020003039","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]}}}